Tim Opler goes over the basics of AI and then delves into key opportunities for the use of AI in drug discovery, clinical trials and other settings.
AI in Biopharma
Stifel
Tim Opler
Research
288 Pages
Key Takeaways
Adoption: AI’s biggest impact may therefore be accelerating the spread and implementation of existing knowledge, not just discovering new drugs.
Drug Discovery Acceleration: AI could shorten the time from discovery to clinical candidate and reduce the trial-and-error nature of drug development.
Information Dissemination: AI tools combined with more open scientific data and collaboration could radically change how medical insights are produced and disseminated.